These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32946483)

  • 1. Generation of induced neural stem cells with inducible IDH1R132H for analysis of glioma development and drug testing.
    Rosiak-Stec K; Grot D; Rieske P
    PLoS One; 2020; 15(9):e0239325. PubMed ID: 32946483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IDH1-mutated transgenic zebrafish lines: An in-vivo model for drug screening and functional analysis.
    Gao Y; de Wit M; Struys EA; van der Linde HCZ; Salomons GS; Lamfers MLM; Willemsen R; Sillevis Smitt PAE; French PJ
    PLoS One; 2018; 13(6):e0199737. PubMed ID: 29953513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation of isocitrate dehydrogenase 1 induces glioma cell proliferation via nuclear factor-κB activation in a hypoxia-inducible factor 1-α dependent manner.
    Wang G; Sai K; Gong F; Yang Q; Chen F; Lin J
    Mol Med Rep; 2014 May; 9(5):1799-805. PubMed ID: 24626950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IDH1R132H in Neural Stem Cells: Differentiation Impaired by Increased Apoptosis.
    Rosiak K; Smolarz M; Stec WJ; Peciak J; Grzela D; Winiecka-Klimek M; Stoczynska-Fidelus E; Krynska B; Piaskowski S; Rieske P
    PLoS One; 2016; 11(5):e0154726. PubMed ID: 27145078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATRX loss promotes immunosuppressive mechanisms in IDH1 mutant glioma.
    Hu C; Wang K; Damon C; Fu Y; Ma T; Kratz L; Lal B; Ying M; Xia S; Cahill DP; Jackson CM; Lim M; Laterra J; Li Y
    Neuro Oncol; 2022 Jun; 24(6):888-900. PubMed ID: 34951647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isocitrate Dehydrogenase Mutations are Better Prognostic Marker than O6-methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastomas - a Retrospective, Single-centre Molecular Genetics Study of Gliomas.
    Houdova Megova M; Drábek J; Dwight Z; Trojanec R; Koudeláková V; Vrbková J; Kalita O; Mlcochova S; Rabcanova M; Hajdúch M
    Klin Onkol; 2017; 30(5):361-371. PubMed ID: 29031038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of isocitrate dehydrogenase-1R¹³²H enhances the proliferation of A172 glioma cells via aerobic glycolysis.
    Nie Q; Guo P; Guo L; Lan J; Lin Y; Guo F; Zhou S; Ge J; Mao Q; Li X; Qiu Y
    Mol Med Rep; 2015 May; 11(5):3715-21. PubMed ID: 25586175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of isocitrate dehydrogenase 1 gene R132H and its diagnostic application in glioma].
    PIAO YS; LU DH; ZHANG XJ; TANG GC; YANG H
    Zhonghua Bing Li Xue Za Zhi; 2011 Mar; 40(3):156-60. PubMed ID: 21575384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. To be Wild or Mutant: Role of Isocitrate Dehydrogenase 1 (IDH1) and 2-Hydroxy Glutarate (2-HG) in Gliomagenesis and Treatment Outcome in Glioma.
    Bhavya B; Anand CR; Madhusoodanan UK; Rajalakshmi P; Krishnakumar K; Easwer HV; Deepti AN; Gopala S
    Cell Mol Neurobiol; 2020 Jan; 40(1):53-63. PubMed ID: 31485826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant IDH1 Disrupts the Mouse Subventricular Zone and Alters Brain Tumor Progression.
    Pirozzi CJ; Carpenter AB; Waitkus MS; Wang CY; Zhu H; Hansen LJ; Chen LH; Greer PK; Feng J; Wang Y; Bock CB; Fan P; Spasojevic I; McLendon RE; Bigner DD; He Y; Yan H
    Mol Cancer Res; 2017 May; 15(5):507-520. PubMed ID: 28148827
    [No Abstract]   [Full Text] [Related]  

  • 11. IDH1R132H Promotes Malignant Transformation of Benign Prostatic Epithelium by Dysregulating MicroRNAs: Involvement of IGF1R-AKT/STAT3 Signaling Pathway.
    Zhang L; Qi M; Feng T; Hu J; Wang L; Li X; Gao W; Liu H; Jiao M; Wu Z; Bai X; Bie Y; Liu L; Han B
    Neoplasia; 2018 Feb; 20(2):207-217. PubMed ID: 29331887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptive Evolution of the GDH2 Allosteric Domain Promotes Gliomagenesis by Resolving IDH1
    Waitkus MS; Pirozzi CJ; Moure CJ; Diplas BH; Hansen LJ; Carpenter AB; Yang R; Wang Z; Ingram BO; Karoly ED; Mohney RP; Spasojevic I; McLendon RE; Friedman HS; He Y; Bigner DD; Yan H
    Cancer Res; 2018 Jan; 78(1):36-50. PubMed ID: 29097607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling the diffusion of D-2-hydroxyglutarate from IDH1 mutant gliomas in the central nervous system.
    Linninger A; Hartung GA; Liu BP; Mirkov S; Tangen K; Lukas RV; Unruh D; James CD; Sarkaria JN; Horbinski C
    Neuro Oncol; 2018 Aug; 20(9):1197-1206. PubMed ID: 29660019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EZH2 Inhibition Sensitizes IDH1R132H-Mutant Gliomas to Histone Deacetylase Inhibitor.
    Sprinzen L; Garcia F; Mela A; Lei L; Upadhyayula P; Mahajan A; Humala N; Manier L; Caprioli R; Quiñones-Hinojosa A; Casaccia P; Canoll P
    Cells; 2024 Jan; 13(3):. PubMed ID: 38334611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demethylation and epigenetic modification with 5-azacytidine reduces IDH1 mutant glioma growth in combination with temozolomide.
    Yamashita AS; da Costa Rosa M; Borodovsky A; Festuccia WT; Chan T; Riggins GJ
    Neuro Oncol; 2019 Feb; 21(2):189-200. PubMed ID: 30184215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse glioma - Rare homozygous IDH point mutation, is it an oncogenetic mechanism?
    Singh A; Gurav M; Dhanavade S; Shetty O; Epari S
    Neuropathology; 2017 Dec; 37(6):582-585. PubMed ID: 28782849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic silencing of XAF1 in high-grade gliomas is associated with IDH1 status and improved clinical outcome.
    Reich TR; Switzeny OJ; Renovanz M; Sommer C; Kaina B; Christmann M; Tomicic MT
    Oncotarget; 2017 Feb; 8(9):15071-15084. PubMed ID: 28122345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isocitrate dehydrogenase mutation as a therapeutic target in gliomas.
    Han CH; Batchelor TT
    Chin Clin Oncol; 2017 Jun; 6(3):33. PubMed ID: 28705010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiosynthesis and biological evaluation of [
    Lai TH; Wenzel B; Dukić-Stefanović S; Teodoro R; Arnaud L; Maisonial-Besset A; Weber V; Moldovan RP; Meister S; Pietzsch J; Kopka K; Juratli TA; Deuther-Conrad W; Toussaint M
    Eur J Nucl Med Mol Imaging; 2024 Mar; 51(4):1085-1096. PubMed ID: 37982850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-148a increases glioma cell migration and invasion by downregulating GADD45A in human gliomas with IDH1 R132H mutations.
    Cui D; Sajan P; Shi J; Shen Y; Wang K; Deng X; Zhou L; Hu P; Gao L
    Oncotarget; 2017 Apr; 8(15):25345-25361. PubMed ID: 28445981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.